Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431559/
https://www.ncbi.nlm.nih.gov/pubmed/37601463
http://dx.doi.org/10.1097/AS9.0000000000000290
_version_ 1785091229798629376
collection PubMed
description
format Online
Article
Text
id pubmed-10431559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104315592023-08-18 Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum Ann Surg Open Erratum Wolters Kluwer Health, Inc. 2023-06-12 /pmc/articles/PMC10431559/ /pubmed/37601463 http://dx.doi.org/10.1097/AS9.0000000000000290 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Erratum
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
title Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
title_full Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
title_fullStr Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
title_full_unstemmed Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
title_short Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
title_sort benefit of primary tumor resection in stage iv, grade 1 and 2, pancreatic neuroendocrine tumors: a propensity-score matched cohort study: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431559/
https://www.ncbi.nlm.nih.gov/pubmed/37601463
http://dx.doi.org/10.1097/AS9.0000000000000290

Ejemplares similares